Meeder Asset Management Inc Celcuity Inc. Transaction History

Meeder Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$11.96 - $19.35 $1,160 - $1,876	-97 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$17.35 - $24.87 $1,682 - $2,412	97 New	97 $1,000
Q2 2021 Aug 09, 2021	SELL	$14.25 - $30.93 $14,506 - $31,486	-1,018 Closed	0 $0
Q1 2021 Apr 28, 2021	BUY	$10.43 - $17.8 $10,617 - $18,120	1,018 New	1,018 $15,000
Q4 2020 Feb 09, 2021	SELL	$5.13 - $11.72 $5,222 - $11,930	-1,018 Closed	0 $0
Q3 2018 Nov 02, 2018	SELL	$20.96 - $30.77 $8,300 - $12,184	-396 Reduced 28.01%	1,018 $0
Q2 2018 Jul 24, 2018	BUY	$16.13 - $26.99 $20,533 - $34,358	1,273 Added 902.84%	1,414 $0
Q1 2018 May 03, 2018	BUY	$13.55 - $21.3 $1,910 - $3,003	141 New	141 $2,000

107

30.3M

30.8K

152K

Ticker CELC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,941,300
Market Cap $187M
Description
Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Meeder Asset Management Inc with notifications on news.